{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:51:00Z","timestamp":1794293460065,"version":"4.9.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5K08GM126315"],"award-info":[{"award-number":["5K08GM126315"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18TPA34170188"],"award-info":[{"award-number":["18TPA34170188"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG056919"],"award-info":[{"award-number":["AG056919"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heart disease remains the leading cause of mortality globally, so further investigation is required to identify its underlying mechanisms and potential targets for treatment and prevention. Mitsugumin 53 (MG53), also known as TRIM72, is a TRIM family protein that was found to be involved in cell membrane repair and primarily found in striated muscle. Its role in skeletal muscle regeneration and myogenesis has been well documented. However, accumulating evidence suggests that MG53 has a potentially protective role in heart tissue, including in ischemia\/reperfusion injury of the heart, cardiomyocyte membrane injury repair, and atrial fibrosis. This review summarizes the regulatory role of MG53 in cardiac tissues, current debates regarding MG53 in diabetes and diabetic cardiomyopathy, as well as highlights potential clinical applications of MG53 in treating cardiac pathologies.<\/jats:p>","DOI":"10.1186\/s13578-021-00629-x","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T13:03:17Z","timestamp":1624885397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cardiac effects and clinical applications of MG53"],"prefix":"10.1186","volume":"11","author":[{"given":"Weina","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dathe Z.","family":"Benissan-Messan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-7435","authenticated-orcid":false,"given":"Chuanxi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H. U.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"629_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/bies.20304","volume":"27","author":"G Meroni","year":"2005","unstructured":"Meroni G, Diez-Roux G. TRIM\/RBCC, a novel class of \u201csingle protein RING finger\u201d E3 ubiquitin ligases. BioEssays. 2005;27:1147\u201357.","journal-title":"BioEssays"},{"key":"629_CR2","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","volume":"20","author":"A Reymond","year":"2001","unstructured":"Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20:2140\u201351.","journal-title":"EMBO J"},{"key":"629_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0968-0004(97)01049-9","volume":"22","author":"C Ponting","year":"1997","unstructured":"Ponting C, Schultz J, Bork P. SPRY domains in ryanodine receptors (Ca2+-release channels). Trends Biochem Sci. 1997;22:193\u20134.","journal-title":"Trends Biochem Sci"},{"key":"629_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ncb1812","volume":"11","author":"C Cai","year":"2009","unstructured":"Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, et al. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol. 2009;11:56\u201364.","journal-title":"Nat Cell Biol"},{"key":"629_CR5","doi-asserted-by":"publisher","first-page":"15894","DOI":"10.1074\/jbc.M109.009589","volume":"284","author":"C Cai","year":"2009","unstructured":"Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, et al. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J Biol Chem. 2009;284:15894\u2013902.","journal-title":"J Biol Chem"},{"key":"629_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.RES.57.6.864","volume":"57","author":"C Steenbergen","year":"1985","unstructured":"Steenbergen C, Hill ML, Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res. 1985;57:864\u201375.","journal-title":"Circ Res"},{"key":"629_CR7","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124\u201336.","journal-title":"Circulation"},{"key":"629_CR8","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1161\/CIRCULATIONAHA.110.954628","volume":"121","author":"CM Cao","year":"2010","unstructured":"Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, et al. MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation. 2010;121:2565\u201374.","journal-title":"Circulation"},{"key":"629_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jamcollsurg.2005.12.002","volume":"202","author":"PR Crisostomo","year":"2006","unstructured":"Crisostomo PR, Wairiuko GM, Wang M, Tsai BM, Morrell ED, et al. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg. 2006;202:797\u2013812.","journal-title":"J Am Coll Surg"},{"key":"629_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/cvr\/cvp298","volume":"84","author":"G Heusch","year":"2009","unstructured":"Heusch G. No RISK, no \u2026 cardioprotection? A critical perspective. Cardiovasc Res. 2009;84:173\u20135.","journal-title":"Cardiovasc Res"},{"key":"629_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","volume":"47","author":"S Lecour","year":"2009","unstructured":"Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell Cardiol. 2009;47:32\u201340.","journal-title":"J Mol Cell Cardiol"},{"key":"629_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cvr\/cvp274","volume":"84","author":"L Lacerda","year":"2009","unstructured":"Lacerda L, Somers S, Opie LH, Lecour S. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res. 2009;84:201\u20138.","journal-title":"Cardiovasc Res"},{"key":"629_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101:660\u20137.","journal-title":"Circulation"},{"key":"629_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/01.RES.0000124394.01180.BE","volume":"94","author":"I Shiraishi","year":"2004","unstructured":"Shiraishi I, Melendez J, Ahn Y, Skavdahl M, Murphy E, et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res. 2004;94:884\u201391.","journal-title":"Circ Res"},{"key":"629_CR15","doi-asserted-by":"publisher","first-page":"40343","DOI":"10.1074\/jbc.M305964200","volume":"278","author":"AL Howes","year":"2003","unstructured":"Howes AL, Arthur JF, Zhang T, Miyamoto S, Adams JW, et al. Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletion. J Biol Chem. 2003;278:40343\u201351.","journal-title":"J Biol Chem"},{"key":"629_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/01.RES.0000012567.95445.55","volume":"90","author":"H Tong","year":"2002","unstructured":"Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase\u2013dependent pathway is cardioprotective. Circ Res. 2002;90:377\u20139.","journal-title":"Circ Res"},{"key":"629_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cvr\/cvr029","volume":"91","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Lv F, Jin L, Peng W, Song R, et al. MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res. 2011;91:108\u201315.","journal-title":"Cardiovasc Res"},{"key":"629_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCULATIONAHA.119.044998","volume":"142","author":"D Shan","year":"2020","unstructured":"Shan D, Guo S, Wu HK, Lv F, Jin L, et al. Cardiac ischemic preconditioning promotes MG53 secretion through H2O2-activated protein kinase C-delta signaling. Circulation. 2020;142:1077\u201391.","journal-title":"Circulation"},{"key":"629_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/ars.2010.3531","volume":"14","author":"P Pagliaro","year":"2011","unstructured":"Pagliaro P, Penna C. Cardiac postconditioning. Antioxid Redox Signal. 2011;14:777\u20139.","journal-title":"Antioxid Redox Signal"},{"key":"629_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/01.RES.0000020201.44772.67","volume":"90","author":"KB Pasumarthi","year":"2002","unstructured":"Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res. 2002;90:1044\u201354.","journal-title":"Circ Res"},{"key":"629_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCRESAHA.109.215822","volume":"107","author":"X Wang","year":"2010","unstructured":"Wang X, Xie W, Zhang Y, Lin P, Han L, et al. Cardioprotection of ischemia\/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res. 2010;107:76\u201383.","journal-title":"Circ Res"},{"key":"629_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/mt.2012.5","volume":"20","author":"B He","year":"2012","unstructured":"He B, Tang RH, Weisleder N, Xiao B, Yuan Z, et al. Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in delta-Sarcoglycan-deficient hamsters. Mol Ther. 2012;20:727\u201335.","journal-title":"Mol Ther"},{"key":"629_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/1689","volume":"20","author":"R Bashir","year":"1998","unstructured":"Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20:37\u201342.","journal-title":"Nat Genet"},{"key":"629_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4161\/chan.3.1.7571","volume":"3","author":"H Masumiya","year":"2009","unstructured":"Masumiya H, Asaumi Y, Nishi M, Minamisawa S, Adachi-Akahane S, et al. Mitsugumin 53-mediated maintenance of K+ currents in cardiac myocytes. Channels (Austin). 2009;3:6\u201311.","journal-title":"Channels (Austin)"},{"key":"629_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1524-475X.2006.00179.x","volume":"15","author":"AB Lansdown","year":"2007","unstructured":"Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen. 2007;15:2\u201316.","journal-title":"Wound Repair Regen"},{"key":"629_CR26","doi-asserted-by":"publisher","first-page":"13830","DOI":"10.1074\/jbc.M114.620690","volume":"290","author":"C Cai","year":"2015","unstructured":"Cai C, Lin P, Zhu H, Ko JK, Hwang M, et al. Zinc binding to MG53 protein facilitates repair of injury to cell membranes. J Biol Chem. 2015;290:13830\u20139.","journal-title":"J Biol Chem"},{"key":"629_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.yjmcc.2014.01.010","volume":"69","author":"MJ Kohr","year":"2014","unstructured":"Kohr MJ, Evangelista AM, Ferlito M, Steenbergen C, Murphy E. S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death. J Mol Cell Cardiol. 2014;69:67\u201374.","journal-title":"J Mol Cell Cardiol"},{"key":"629_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.yjmcc.2017.08.007","volume":"112","author":"C Zhang","year":"2017","unstructured":"Zhang C, Chen B, Wang Y, Guo A, Tang Y, et al. MG53 is dispensable for T-tubule maturation but critical for maintaining T-tubule integrity following cardiac stress. J Mol Cell Cardiol. 2017;112:123\u201330.","journal-title":"J Mol Cell Cardiol"},{"key":"629_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1034\/j.1600-0854.2002.30702.x","volume":"3","author":"B Zhang","year":"2002","unstructured":"Zhang B, Zelhof AC. Amphiphysins: raising the BAR for synaptic vesicle recycling and membrane dynamics. Bin-Amphiphysin-Rvsp Traffic. 2002;3:452\u201360.","journal-title":"Bin-Amphiphysin-Rvsp Traffic"},{"key":"629_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10974-007-9121-x","volume":"28","author":"A Di Maio","year":"2007","unstructured":"Di Maio A, Karko K, Snopko RM, Mejia-Alvarez R, Franzini-Armstrong C. T-tubule formation in cardiacmyocytes: two possible mechanisms? J Muscle Res Cell Motil. 2007;28:231\u201341.","journal-title":"J Muscle Res Cell Motil"},{"key":"629_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ncb0109-7","volume":"11","author":"P McNeil","year":"2009","unstructured":"McNeil P. Membrane repair redux: redox of MG53. Nat Cell Biol. 2009;11:7\u20139.","journal-title":"Nat Cell Biol"},{"key":"629_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11834","volume":"494","author":"R Song","year":"2013","unstructured":"Song R, Peng W, Zhang Y, Lv F, Wu HK, et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature. 2013;494:375\u20139.","journal-title":"Nature"},{"key":"629_CR33","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/ncomms3354","volume":"4","author":"JS Yi","year":"2013","unstructured":"Yi JS, Park JS, Ham YM, Nguyen N, Lee NR, et al. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun. 2013;4:2354.","journal-title":"Nat Commun"},{"key":"629_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00395-017-0634-1","volume":"112","author":"Q Wang","year":"2017","unstructured":"Wang Q, Yu Y, Zhang P, Chen Y, Li C, et al. The crucial role of activin A\/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Basic Res Cardiol. 2017;112:47.","journal-title":"Basic Res Cardiol"},{"key":"629_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00395-017-0647-9","volume":"112","author":"SH Chang","year":"2017","unstructured":"Chang SH, Yeh YH, Lee JL, Hsu YJ, Kuo CT, et al. Transforming growth factor-beta-mediated CD44\/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res Cardiol. 2017;112:58.","journal-title":"Basic Res Cardiol"},{"key":"629_CR36","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1002\/pmic.201500143","volume":"15","author":"RJ Huber","year":"2015","unstructured":"Huber RJ, O\u2019Day DH. Proteomic profiling of the extracellular matrix (slime sheath) of Dictyostelium discoideum. Proteomics. 2015;15:3315\u20139.","journal-title":"Proteomics"},{"key":"629_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbrc.2015.05.131","volume":"464","author":"XQ Chen","year":"2015","unstructured":"Chen XQ, Zhang DL, Zhang MJ, Guo M, Zhan YY, et al. TRIF promotes angiotensin II-induced cross-talk between fibroblasts and macrophages in atrial fibrosis. Biochem Biophys Res Commun. 2015;464:100\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"629_CR38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.yexcr.2017.12.007","volume":"362","author":"J Guo","year":"2018","unstructured":"Guo J, Jia F, Jiang Y, Li Q, Yang Y, et al. Potential role of MG53 in the regulation of transforming-growth-factor-beta1-induced atrial fibrosis and vulnerability to atrial fibrillation. Exp Cell Res. 2018;362:436\u201343.","journal-title":"Exp Cell Res"},{"key":"629_CR39","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000443703","volume":"134","author":"JQ Zhao","year":"2016","unstructured":"Zhao JQ, Lei H. Tripartite motif protein 72 regulates the proliferation and migration of rat cardiac fibroblasts via the transforming growth factor-beta signaling pathway. Cardiology. 2016;134:340\u20136.","journal-title":"Cardiology"},{"key":"629_CR40","doi-asserted-by":"publisher","first-page":"17749","DOI":"10.1002\/jcp.28400","volume":"234","author":"X Chen","year":"2019","unstructured":"Chen X, Su J, Feng J, Cheng L, Li Q, et al. TRIM72 contributes to cardiac fibrosis via regulating STAT3\/Notch-1 signaling. J Cell Physiol. 2019;234:17749\u201356.","journal-title":"J Cell Physiol"},{"key":"629_CR41","doi-asserted-by":"publisher","first-page":"24592","DOI":"10.1074\/jbc.M115.680074","volume":"290","author":"H Li","year":"2015","unstructured":"Li H, Duann P, Lin PH, Zhao L, Fan Z, et al. Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair. J Biol Chem. 2015;290:24592\u2013603.","journal-title":"J Biol Chem"},{"key":"629_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009960","author":"TMA Adesanya","year":"2019","unstructured":"Adesanya TMA, Russell M, Park KH, Zhou XY, Sermersheim MA, et al. MG53 protein protects aortic valve interstitial cells from membrane injury and fibrocalcific remodeling. J Am Heart Assoc. 2019. https:\/\/doi.org\/10.1161\/JAHA.118.009960.","journal-title":"J Am Heart Assoc"},{"key":"629_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"629_CR44","first-page":"7413693","volume":"2020","author":"X Han","year":"2020","unstructured":"Han X, Chen DL, Liufu N, Ji FT, Zeng QS, et al. MG53 protects against sepsis-induced myocardial dysfunction by upregulating peroxisome proliferator-activated receptor-alpha. Oxidative Med Cell Longev. 2020;2020:7413693.","journal-title":"Oxidative Med Cell Longev."},{"key":"629_CR45","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1074\/jbc.M808866200","volume":"284","author":"C Cai","year":"2009","unstructured":"Cai C, Masumiya H, Weisleder N, Pan Z, Nishi M, et al. MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem. 2009;284:3314\u201322.","journal-title":"J Biol Chem"},{"key":"629_CR46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/CIRCULATIONAHA.114.012285","volume":"131","author":"F Liu","year":"2015","unstructured":"Liu F, Song R, Feng Y, Guo J, Chen Y, et al. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor alpha. Circulation. 2015;131:795\u2013804.","journal-title":"Circulation"},{"key":"629_CR47","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/CIRCULATIONAHA.118.037216","volume":"139","author":"HK Wu","year":"2019","unstructured":"Wu HK, Zhang Y, Cao CM, Hu X, Fang M, et al. Glucose-sensitive myokine\/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis. Circulation. 2019;139:901\u201314.","journal-title":"Circulation"},{"key":"629_CR48","doi-asserted-by":"publisher","first-page":"1564386","DOI":"10.1155\/2016\/1564386","volume":"2016","author":"J Qi","year":"2016","unstructured":"Qi J, Yang B, Ren C, Fu J, Zhang J. Swimming exercise alleviated insulin resistance by regulating tripartite motif family protein 72 expression and AKT signal pathway in Sprague-Dawley rats fed with high-fat diet. J Diabetes Res. 2016;2016:1564386.","journal-title":"J Diabetes Res"},{"key":"629_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.abb.2017.12.015","volume":"639","author":"SS Reddy","year":"2018","unstructured":"Reddy SS, Shruthi K, Prabhakar YK, Sailaja G, Reddy GB. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats. Arch Biochem Biophys. 2018;639:16\u201325.","journal-title":"Arch Biochem Biophys"},{"key":"629_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124128","author":"H Ma","year":"2015","unstructured":"Ma H, Liu J, Bian Z, Cui Y, Zhou X, et al. Effect of metabolic syndrome on mitsugumin 53 expression and function. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0124128.","journal-title":"PLoS ONE"},{"key":"629_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/SHK.0000000000000737","volume":"47","author":"LL Ma","year":"2017","unstructured":"Ma LL, Kong FJ, Guo JJ, Zhu JB, Shi HT, et al. Hypercholesterolemia abrogates remote ischemic preconditioning-induced cardioprotection: role of reperfusion injury salvage kinase signals. Shock. 2017;47:363\u20139.","journal-title":"Shock"},{"key":"629_CR52","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1016\/j.ijcard.2013.06.037","volume":"168","author":"LL Ma","year":"2013","unstructured":"Ma LL, Zhang FJ, Qian LB, Kong FJ, Sun JF, et al. Hypercholesterolemia blocked sevoflurane-induced cardioprotection against ischemia-reperfusion injury by alteration of the MG53\/RISK\/GSK3beta signaling. Int J Cardiol. 2013;168:3671\u20138.","journal-title":"Int J Cardiol"},{"key":"629_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076652","author":"Y Xu","year":"2013","unstructured":"Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, et al. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0076652.","journal-title":"PLoS ONE"},{"key":"629_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053887","author":"H Yuan","year":"2013","unstructured":"Yuan H, Niu Y, Liu X, Yang F, Niu W, et al. Proteomic analysis of skeletal muscle in insulin-resistant mice: response to 6-week aerobic exercise. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0053887.","journal-title":"PLoS ONE"},{"key":"629_CR55","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2337\/db15-0823","volume":"65","author":"P Zabielski","year":"2016","unstructured":"Zabielski P, Lanza IR, Gopala S, Heppelmann CJ, Bergen HR 3rd, et al. Altered skeletal muscle mitochondrial proteome as the basis of disruption of mitochondrial function in diabetic mice. Diabetes. 2016;65:561\u201373.","journal-title":"Diabetes"},{"key":"629_CR56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/372182a0","volume":"372","author":"H Tamemoto","year":"1994","unstructured":"Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 1994;372:182\u20136.","journal-title":"Nature"},{"key":"629_CR57","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1172\/JCI119250","volume":"99","author":"Y Terauchi","year":"1997","unstructured":"Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, et al. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest. 1997;99:861\u20136.","journal-title":"J Clin Invest"},{"key":"629_CR58","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1101\/gad.1034802","volume":"16","author":"PG Laustsen","year":"2002","unstructured":"Laustsen PG, Michael MD, Crute BE, Cohen SE, Ueki K, et al. Lipoatrophic diabetes in Irs1(-\/-)\/Irs3(-\/-) double knockout mice. Genes Dev. 2002;16:3213\u201322.","journal-title":"Genes Dev"},{"key":"629_CR59","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2337\/db13-1872","volume":"63","author":"M Caruso","year":"2014","unstructured":"Caruso M, Ma D, Msallaty Z, Lewis M, Seyoum B, et al. Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes. Diabetes. 2014;63:1933\u201347.","journal-title":"Diabetes"},{"key":"629_CR60","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2337\/db19-0807","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Bian Z, Jiang Q, Wang X, Zhou X, et al. MG53 does not manifest the development of diabetes in db\/db mice. Diabetes. 2020;69:1052\u201364.","journal-title":"Diabetes"},{"key":"629_CR61","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.yexcr.2013.02.016","volume":"319","author":"YM Ham","year":"2013","unstructured":"Ham YM, Mahoney SJ. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72. Exp Cell Res. 2013;319:1451\u201362.","journal-title":"Exp Cell Res"},{"issue":"18","key":"629_CR62","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.118.029413","volume":"139","author":"W Liu","year":"2019","unstructured":"Liu W, Wang G, Zhang C, Ding W, Cheng W, et al. MG53, a novel regulator of KChIP2 and Ito, f, plays a critical role in electrophysiological remodeling in cardiac hypertrophy. Circulation. 2019;139(18):2142\u201356.","journal-title":"Circulation"},{"key":"629_CR63","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1038\/s41467-019-12483-0","volume":"10","author":"Z Bian","year":"2019","unstructured":"Bian Z, Wang Q, Zhou X, Tan T, Park KH, et al. Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function. Nat Commun. 2019;10:4659.","journal-title":"Nat Commun"},{"key":"629_CR64","first-page":"e186","volume":"140","author":"H Zhu","year":"2019","unstructured":"Zhu H, Hsueh W, Whitson BA. Letter by Zhu et al regarding article, \u201cGlucose-sensitive myokine\/cardiokine mg53 regulates systemic insulin response and metabolic homeostasis.\u201d Circulation. 2019;140:e186\u20137.","journal-title":"Circulation"},{"issue":"2","key":"629_CR65","doi-asserted-by":"publisher","first-page":"e0245179","DOI":"10.1371\/journal.pone.0245179","volume":"16","author":"CTS Philouze","year":"2021","unstructured":"Philouze CTS, Cremers B, Caliez A, Lamarche G, Bernard C, Provost N, Delerive P. MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle. PLoS ONE. 2021;16(2):e0245179.","journal-title":"PLoS ONE"},{"key":"629_CR66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/cvr\/cvw017","volume":"110","author":"FA Lemckert","year":"2016","unstructured":"Lemckert FA, Bournazos A, Eckert DM, Kenzler M, Hawkes JM, et al. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor. Cardiovasc Res. 2016;110:178\u201387.","journal-title":"Cardiovasc Res"},{"key":"629_CR67","doi-asserted-by":"publisher","first-page":"C639","DOI":"10.1152\/ajpcell.00167.2013","volume":"306","author":"KD Marshall","year":"2014","unstructured":"Marshall KD, Edwards MA, Krenz M, Davis JW, Baines CP. Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes. Am J Physiol Cell Physiol. 2014;306:C639-647.","journal-title":"Am J Physiol Cell Physiol"},{"key":"629_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yjmcc.2014.12.010","volume":"80","author":"J Liu","year":"2015","unstructured":"Liu J, Zhu H, Zheng Y, Xu Z, Li L, et al. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. J Mol Cell Cardiol. 2015;80:10\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"629_CR69","first-page":"1658","volume":"11","author":"HY Xie","year":"2020","unstructured":"Xie HY, Wang YQ, Zhu TQ, Feng S, Yan ZJ, et al. Serum MG53\/TRIM72 is associated with the presence and severity of coronary artery disease and acute myocardial infarction. Front Physiol. 2020;11:1658.","journal-title":"Front Physiol"},{"key":"629_CR70","doi-asserted-by":"publisher","first-page":"139ra185","DOI":"10.1126\/scitranslmed.3003921","volume":"4","author":"N Weisleder","year":"2012","unstructured":"Weisleder N, Takizawa N, Lin P, Wang X, Cao C, et al. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med. 2012;4:139ra185.","journal-title":"Sci Transl Med"},{"key":"629_CR71","doi-asserted-by":"publisher","first-page":"279ra236","DOI":"10.1126\/scitranslmed.3010755","volume":"7","author":"P Duann","year":"2015","unstructured":"Duann P, Li H, Lin P, Tan T, Wang Z, et al. MG53-mediated cell membrane repair protects against acute kidney injury. Sci Transl Med. 2015;7:279ra236.","journal-title":"Sci Transl Med"},{"key":"629_CR72","doi-asserted-by":"publisher","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","volume":"285","author":"ZQ Zhao","year":"2003","unstructured":"Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-588.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"629_CR73","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mus.24160","volume":"49","author":"BT Corona","year":"2014","unstructured":"Corona BT, Garg K, Roe JL, Zhu H, Park KH, et al. Effect of recombinant human MG53 protein on tourniquet-induced ischemia-reperfusion injury in rat muscle. Muscle Nerve. 2014;49:919\u201321.","journal-title":"Muscle Nerve"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00629-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00629-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00629-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T13:08:39Z","timestamp":1624885719000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00629-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00629-x","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have their consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JM hold equity interest in TRIM-edicine, Inc., a university spin-off biotechnology company that develops MG53 for regenerative medicine application. Rutgers University and Ohio State University own the Intellectual property related to MG53. All the other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}